Clinical Trials Arena June 12, 2024
Pooling drug products in clinical trials sounds like an easy way to reduce waste and cut costs. So why don’t more sponsors do it?
Around ten years ago, everyone was talking about pooling supplies in clinical trials. Sharing drug products, especially in-house, seems like a no brainer. It saves on resources, costs and supply chains.
Pooling inventory across program levels can greatly reduce manufacturing and bulk supply costs as well as packaging needs. Overages can be managed at the program level, rather than each protocol individually, and this approach allows for continuous assessment of recruitment rates, shipments and storage needs, lowering costs.
It also supports sites with limited storage capacity and reduces potential patient risk, by ensuring continuity of supply,...
Today's Sponsors
Today's Sponsor